|Articles|March 15, 2004
FDA approves generic equivalent to ophthalmic ointment
The FDA has approved Akorn Inc.'s abbreviated new drug application for neomycin and polymyxin B sulfates, and bacitracin zinc ophthalmic ointment USP, a generic therapeutic equivalent to Monarch Pharmaceuticals' Neosporin ophthalmic ointment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
2
SparingVision completes PRODYGY trial patient dosing with SPVN06
3
Q&A: Optimizing the ocular surface for light adjustable lens technology
4
PRIMA System: A major step in the battle against GA
5
























